Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Zoledronic Acid MeSH Descriptor Data 2026


MeSH Heading
Zoledronic Acid
Tree Number(s)
D02.705.429.500.942
D03.383.129.308.990
Unique ID
D000077211
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077211
Scope Note
An imidobisphosphonate inhibitor of BONE RESORPTION that is used for the treatment of malignancy-related HYPERCALCEMIA; OSTEITIS DEFORMANS; and OSTEOPOROSIS.
Entry Term(s)
2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
CGP 42'446
CGP 42446A
CGP-42'446
CGP-42446
Zoledronate
Zoledronic Acid Anhydrous
Zometa
Pharm Action
Bone Density Conservation Agents
Registry Numbers
6XC1PAD3KF
70HZ18PH24
158859-43-9
0
Related Numbers
118072-93-8
158859-43-9
70HZ18PH24
Public MeSH Note
2019; ZOLEDRONIC ACID was indexed under DIPHOSPHONATES and IMIDAZOLES 1994-2018
History Note
2019 (1994)
Date Introduced
2019/01/01
Last Updated
2019/07/05
Zoledronic Acid Preferred
Zoledronic Acid Anhydrous Narrower
CGP 42446A Narrower
Zometa Narrower
Zoledronate Narrower
page delivered in 0.145s